Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,054 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ONY Biotech Inc. | $1,054 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $1,054 | 2 | ONY Biotech Inc. ($1,054) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2018 | ONY Biotech Inc. | Infasurf (Drug) | Travel and Lodging | Cash or cash equivalent | $905.20 | General |
| Category: Product | ||||||
| 11/08/2018 | ONY Biotech Inc. | Infasurf (Drug) | Travel and Lodging | In-kind items and services | $148.80 | General |
| Category: Product | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 241 | 305 | $25,263 | $8,314 |
| 2022 | 6 | 194 | 220 | $13,214 | $4,163 |
| 2021 | 5 | 164 | 166 | $4,400 | $1,290 |
| 2020 | 8 | 273 | 344 | $26,540 | $8,702 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 77 | $14,012 | $4,971 | 35.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 17 | $5,651 | $1,801 | 31.9% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 86 | 90 | $1,890 | $550.29 | 29.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 48 | 48 | $1,104 | $302.97 | 27.4% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 20 | 20 | $1,120 | $288.48 | 25.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 27 | 27 | $810.00 | $233.28 | 28.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 26 | 26 | $676.00 | $166.40 | 24.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 47 | $8,272 | $2,683 | 32.4% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 25 | 26 | $1,467 | $441.31 | 30.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 66 | 66 | $1,386 | $405.54 | 29.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 39 | 39 | $897.00 | $271.13 | 30.2% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 25 | 25 | $750.00 | $227.52 | 30.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 17 | 17 | $442.00 | $135.22 | 30.6% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 70 | 72 | $1,512 | $423.73 | 28.0% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 42 | 42 | $966.00 | $271.94 | 28.2% |
| 94618 | Test for exercise-induced lung stress | Facility | 2021 | 15 | 15 | $848.00 | $256.94 | 30.3% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 19 | 19 | $570.00 | $191.14 | 33.5% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 18 | 18 | $504.00 | $146.20 | 29.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 31 | 81 | $14,145 | $4,720 | 33.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 12 | 13 | $4,295 | $1,483 | 34.5% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2020 | 84 | 95 | $1,995 | $605.46 | 30.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 13 | 18 | $1,710 | $583.26 | 34.1% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2020 | 54 | 57 | $1,311 | $412.81 | 31.5% |
| 94618 | Test for exercise-induced lung stress | Facility | 2020 | 24 | 24 | $1,344 | $385.29 | 28.7% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2020 | 30 | 30 | $960.00 | $257.98 | 26.9% |
About Dr. Stephen Hall, MD
Dr. Stephen Hall, MD is a Pulmonary Disease healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366549131.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Hall, MD has received a total of $1,054 in payments from pharmaceutical and medical device companies, with $1,054 received in 2018. These payments were reported across 2 transactions from 1 company. The most common payment nature is "Travel and Lodging" ($1,054).
As a Medicare-enrolled provider, Hall has provided services to 872 Medicare beneficiaries, totaling 1,035 services with total Medicare billing of $22,469. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Portland, OR
- Active Since 09/20/2006
- Last Updated 07/12/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1366549131
Products in Payments
- Infasurf (Drug) $1,054
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Portland
Jordan Fein, M.d, M.D
Pulmonary Disease — Payments: $69,409
Granthem Farr, Do, DO
Pulmonary Disease — Payments: $66,353
Melvin Morganroth, Md, MD
Pulmonary Disease — Payments: $23,131
Dr. Bishoy Zakhary, Md, MD
Pulmonary Disease — Payments: $10,967
Rick Balestra, M.d, M.D
Pulmonary Disease — Payments: $9,856
Vikram Sahni, M.d, M.D
Pulmonary Disease — Payments: $4,784